Assessing Cancer Risk Associated with Immunosuppressive TherapiesÂ
Over the past few decades, the dermatologic care of inflammatory skin conditions has been transformed through the growing use of small molecules disease-modifying anti-rheumatic drugs (DMARDs) and targeted biologic therapies. However, alongside the tremendous benefits offered by these therapeutic agents are concerns regarding potential adverse effects, in particular associated risks of cancer development. The controversial […]
Cutaneous Cancer Metastases in Surgical Scar
Discovered in approximately 1.3% cases at the time of primary tumor presentation, cutaneous metastases of cancers are extremely rare. The phenomenon generally occurs several years after primary diagnosis or resection of the primary tumor, commonly secondary to malignant melanoma, cancer of the lung, or breast cancer. Cutaneous metastases occur in 4% to 6.5% of metastatic […]
